• Industries
    • Chemicals
    • Cosmetic & Consumer Products
    • Pharmaceuticals & Medical Devices
    • Biocides
  • Services
    • Chemical and Product Safety
    • Regulatory Strategy and Compliance
    • QSAR Modelling
    • New Approach Methodologies
    • Endocrine disruption
    • Product Stewardship
    • Environmental Risk Assessment of Medicinal Products
  • Team
    • Team
    • Collaborations
  • Insights
    • Insights
    • Cases
    • Publications
  • Careers
  • Contact
  • Industries
    • Chemicals
    • Cosmetic & Consumer Products
    • Pharmaceuticals & Medical Devices
    • Biocides
  • Services
    • Chemical and Product Safety
    • Regulatory Strategy and Compliance
    • QSAR Modelling
    • New Approach Methodologies
    • Endocrine disruption
    • Product Stewardship
    • Environmental Risk Assessment of Medicinal Products
  • Team
    • Team
    • Collaborations
  • Insights
    • Insights
    • Cases
    • Publications
  • Careers
  • Contact
  • You are here:
  • Home
  • Insights
  • ECHA Public activities coordination tool

ECHA Public activities coordination tool

A new version of the Public activities coordination tool (PACT) has been integrated in the European Chemicals Agency (ECHA) website. This searchable and customizable database now includes substances for which dossier evaluation is ongoing and registries of CLP/restriction/SVHC intentions. With this revamped tool, the transparency of authorities’ activities has certainly increased.

The public activities coordination tool (PACT) has been developed by ECHA in order to track the substance-specific activities being undertaken under REACH and the CLP Regulations in line with its Integrated Regulatory Strategy. Together with the Member States, ECHA developed a common screening process, which identifies substances with adverse impacts on human health and the environment, while prioritizing substances for further compliance check, evaluation or EU level risk management measures.

Under the compliance check process, priority is given to chemicals produced over 100 tonnes per year. The main focus is on the higher tier human health and environmental endpoints relevant for identifying CMR (carcinogenic, mutagenic and reprotoxic) and PBT/vPvB ((very) persistent, bioaccumulative and toxic) substances. Inclusion in this searchable list means that the substance is under examination by a Member State or ECHA. If the suspected properties are concluded upon evaluation, further regulatory risk management actions will be imposed after the relevant regulatory list – such as the Candidate List, the restricted substances list, or Annex VI to CLP is updated.

The chart below displays how the activities and regulatory processes relate to each other. It also shows the various lists of substances that result from the work of the authorities and are published by ECHA on its website.


ECHA - Substance of potential concernSource: European Chemicals Agency,
http://echa.europa.eu/

It is of little doubt that PACT has increased the transparency and predictability of authorities’ work which leads up to the more formal REACH and CLP processes. The PACT list is updated on a regular basis once the activities concerning a substance are concluded by ECHA.

 

Suggested reading:

ECHA: Public Activities Co-ordination Tool

ECHA: Substances of potential concern

ECHA: Integrated Regulatory Strategy

 

Author
  • Mr. Sabyasachi Chakraborty

    Mr. Sabyasachi Chakraborty

MORE INSIGHTS

Requirement of second species testing for evaluating developmental toxicity potential

ECHA Public activities coordination tool

Update on the development of a regulatory framework for developmental neurotoxicity testing with specific focus on non-animal testing approaches

13th SETAC Scientific Symposium: Extrapolation of effects across biological levels

Previous thumb

Developments on the identification of potential endocrine disruptors under EU legislation

Next thumb
Scroll

 

ToxMinds are specialised in ensuring product safety and compliance.

We are passionate about toxicology and how emerging scientific developments can be utilised to support our customers in bringing safe, regulatory compliant and sustainable products to the marketplace.

 

 

 

 

Belgium
ToxMinds BV
Avenue de Tervueren 188A, bte 12
B-1150 Brussels Belgium

VAT BE 0877.628.383

Tel: +32 (0)2 762 9145
Email: contact us

 

 

 

 

India
ToxMinds India Consulting Pvt. Ltd.
Unit 305, 3rd Floor, Brigade IRV Centre, Whitefield, Bangalore-560066, India

 

Tel: +91 804 204 19 20
Email: contact us

 

 

 

 

 

LinkedIN
Copyright and disclaimer | Data privacy
  • Home
  • Industries
  • Services
  • Team
  • Insights
  • Careers
  • Contact
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok